
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9607713
[patent_doc_number] => 08784876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Clay-based hemostatic agents and devices for the delivery thereof'
[patent_app_type] => utility
[patent_app_number] => 13/911616
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 6139
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911616
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911616 | Clay-based hemostatic agents and devices for the delivery thereof | Jun 5, 2013 | Issued |
Array
(
[id] => 9937516
[patent_doc_number] => 08987325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Inhibitors of arachidonic acid formation'
[patent_app_type] => utility
[patent_app_number] => 13/893803
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2255
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893803
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/893803 | Inhibitors of arachidonic acid formation | May 13, 2013 | Issued |
Array
(
[id] => 10001338
[patent_doc_number] => 09045416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'WNT protein signalling inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/875170
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 24109
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875170
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875170 | WNT protein signalling inhibitors | Apr 30, 2013 | Issued |
Array
(
[id] => 9034929
[patent_doc_number] => 20130237567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'IMINOSUGARS AND METHODS OF TREATING VIRAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/870341
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5902
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870341
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/870341 | Iminosugars and methods of treating viral diseases | Apr 24, 2013 | Issued |
Array
(
[id] => 10514888
[patent_doc_number] => 09241919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Compositions and methods for the treatment of inflammatory conditions'
[patent_app_type] => utility
[patent_app_number] => 13/865955
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10981
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865955
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/865955 | Compositions and methods for the treatment of inflammatory conditions | Apr 17, 2013 | Issued |
Array
(
[id] => 9034853
[patent_doc_number] => 20130237491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => '4\'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION'
[patent_app_type] => utility
[patent_app_number] => 13/861436
[patent_app_country] => US
[patent_app_date] => 2013-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10583
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13861436
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/861436 | 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication | Apr 11, 2013 | Issued |
Array
(
[id] => 9551788
[patent_doc_number] => 08758834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Method for enhancing sports scores'
[patent_app_type] => utility
[patent_app_number] => 13/860234
[patent_app_country] => US
[patent_app_date] => 2013-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5941
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13860234
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/860234 | Method for enhancing sports scores | Apr 9, 2013 | Issued |
Array
(
[id] => 8989352
[patent_doc_number] => 20130216633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'Articles and Compositions for Enhancing Sports Scores'
[patent_app_type] => utility
[patent_app_number] => 13/847166
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4499
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847166
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/847166 | Articles and Compositions for Enhancing Sports Scores | Mar 18, 2013 | Abandoned |
Array
(
[id] => 9295381
[patent_doc_number] => 20140039015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/829221
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15651
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13829221
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/829221 | METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9222419
[patent_doc_number] => 20140017194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'Compositions And Methods Of Use Of Phorbol Esters'
[patent_app_type] => utility
[patent_app_number] => 13/794467
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23838
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13794467
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/794467 | Compositions and methods of use of phorbol esters | Mar 10, 2013 | Issued |
Array
(
[id] => 8940540
[patent_doc_number] => 20130190337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'SOLID DOSAGE FORMS OF HIV PROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/789162
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5428
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789162
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/789162 | SOLID DOSAGE FORMS OF HIV PROTEASE INHIBITORS | Mar 6, 2013 | Abandoned |
Array
(
[id] => 9108340
[patent_doc_number] => 20130281472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'COMPOSITION AND METHOD FOR TREATING OR PREVENTING SKELETAL MUSCLE FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/782325
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7780
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/782325 | Composition and method for treating or preventing skeletal muscle fibrosis | Feb 28, 2013 | Issued |
Array
(
[id] => 8916900
[patent_doc_number] => 20130178525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES'
[patent_app_type] => utility
[patent_app_number] => 13/782659
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20449
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782659
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/782659 | Methods and compositions for reducing body fat and adipocytes | Feb 28, 2013 | Issued |
Array
(
[id] => 8904923
[patent_doc_number] => 20130172426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'FAT-REDUCING AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/779225
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17106
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13779225
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/779225 | Fat-reducing agent | Feb 26, 2013 | Issued |
Array
(
[id] => 10056220
[patent_doc_number] => 09095559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Methods of therapeutic monitoring of nitrogen scavenging drugs'
[patent_app_type] => utility
[patent_app_number] => 13/775000
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12915
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13775000
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/775000 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Feb 21, 2013 | Issued |
Array
(
[id] => 8990371
[patent_doc_number] => 20130217652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'SULFINYLBENZYL AND THIOBENZYL DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/771812
[patent_app_country] => US
[patent_app_date] => 2013-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10050
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13771812
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/771812 | SULFINYLBENZYL AND THIOBENZYL DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS | Feb 19, 2013 | Abandoned |
Array
(
[id] => 10038088
[patent_doc_number] => 09078782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Hemostatic fibers and strands'
[patent_app_type] => utility
[patent_app_number] => 13/759963
[patent_app_country] => US
[patent_app_date] => 2013-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 7402
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13759963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/759963 | Hemostatic fibers and strands | Feb 4, 2013 | Issued |
Array
(
[id] => 8940549
[patent_doc_number] => 20130190346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'METHOD OF REDUCING CNS AND GASTROINTESTINAL SIDE AFFECTS ASSOCIATED WITH LONG-TERM, DEXTROMETHORPHAN/LOW-DOSE QUINIDINE COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/752958
[patent_app_country] => US
[patent_app_date] => 2013-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11876
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13752958
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/752958 | METHOD OF REDUCING CNS AND GASTROINTESTINAL SIDE AFFECTS ASSOCIATED WITH LONG-TERM, DEXTROMETHORPHAN/LOW-DOSE QUINIDINE COMBINATION THERAPY | Jan 28, 2013 | Abandoned |
Array
(
[id] => 9710898
[patent_doc_number] => 08835467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'SIR2 regulation'
[patent_app_type] => utility
[patent_app_number] => 13/747543
[patent_app_country] => US
[patent_app_date] => 2013-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13492
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/747543 | SIR2 regulation | Jan 22, 2013 | Issued |
Array
(
[id] => 9421354
[patent_doc_number] => 20140106005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'Compositions And Methods Of Use Of Phorbol Esters In The Treatment Of Neoplasms'
[patent_app_type] => utility
[patent_app_number] => 13/745745
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18929
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745745
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/745745 | Compositions And Methods Of Use Of Phorbol Esters In The Treatment Of Neoplasms | Jan 17, 2013 | Abandoned |